EBS

Emergent Biosolutions Inc

• Benzinga·05/18 15:25

  U.S. CDC Says Will Enhance Screening And Monitoring Of Travelers Arriving From Areas Affected By Ebola Outbreaks; Will Coordinate With Airlines, Others To Manage Travelers Who May Have Already Been Exposed To Ebola; Will Enhance Contract Tracing, Hospital Readiness Nationwide

• TipRanks·05/18 13:18

  Emergent BioSolutions receives Saudi approval for ACAM2000 vaccine

• Benzinga·05/18 13:02

  Emergent BioSolutions Announces Saudi Approval For ACAM2000, Its Smallpox and Mpox Vaccine

• TipRanks·05/04 10:30

  Analysts Offer Insights on Healthcare Companies: Assembly Biosciences (ASMB), Artiva Biotherapeutics, Inc. (ARTV) and Emergent Biosolutions (EBS)

• Simply Wall St·05/02 07:45

  Emergent BioSolutions (EBS) Q1 EPS Profit Challenges Narrative Of Persistent Losses

• TipRanks·05/02 00:45

  Emergent BioSolutions Earnings Call Highlights Turnaround Momentum

• The Motley Fool·05/01 16:26

  Emergent (EBS) Q1 2026 Earnings Transcript

• Seeking Alpha·05/01 15:12

  Emergent outlines $170M-$185M Q2 revenue outlook while maintaining $720M-$760M 2026 revenue guidance

• TipRanks·04/30 22:21

  Emergent BioSolutions Posts Weak Q1 Results Amid Turnaround

• Benzinga·04/30 21:54

  Emergent BioSolutions Q1 2026 Earnings Call: Complete Transcript

• Benzinga·04/30 21:06

  12 Health Care Stocks Moving In Thursday's After-Market Session

• Benzinga·04/30 20:33

  Emergent BioSolutions Sees Q2 Sales $170.000M-$185.000M vs $186.000M Est

• Seeking Alpha·04/30 20:32

  Emergent Biosolutions Non-GAAP EPS of $0.21 beats by $0.46, revenue of $156.1M beats by $11.1M

• Benzinga·04/30 20:32

  Emergent BioSolutions Affirms FY2026 Sales Guidance of $720.000M-$760.000M vs $735.000M Est

• Dow Jones·04/30 20:30

  *Emergent Biosolutions 1Q Adj EPS 21c >EBS